Spots Global Cancer Trial Database for myelodysplastic syndrome(mds)
Every month we try and update this database with for myelodysplastic syndrome(mds) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome | NCT05674539 | Acute Myeloid L... Myelodysplastic... Allogeneic Hema... | Fludarabine and... Fludarabine and... | 18 Years - | Wuhan Union Hospital, China | |
| Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide | NCT01342289 | Hodgkin's Lymph... Leukemia Myelodysplastic... Multiple Myelom... Non Hodgkin's L... | Cyclophosphamid... Fludarabine Total body irra... Mycophenolate M... Tacrolimus 60 Tacrolimus 90 Tacrolimus 120 Bone marrow tra... | 6 Months - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS) | NCT05168904 | Leukemia Myelodysplastic... | fadraciclib | 18 Years - | Cyclacel Pharmaceuticals, Inc. | |
| TPO-Mimetic Use in Children for Hematopoietic Failure | NCT04478227 | Bone Marrow Fai... Aplastic Anemia Thrombocytopeni... Refractory Cyto... Myelodysplastic... | Romiplostim | 0 Years - 21 Years | University of Iowa | |
| A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS) | NCT05168904 | Leukemia Myelodysplastic... | fadraciclib | 18 Years - | Cyclacel Pharmaceuticals, Inc. | |
| Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide | NCT01342289 | Hodgkin's Lymph... Leukemia Myelodysplastic... Multiple Myelom... Non Hodgkin's L... | Cyclophosphamid... Fludarabine Total body irra... Mycophenolate M... Tacrolimus 60 Tacrolimus 90 Tacrolimus 120 Bone marrow tra... | 6 Months - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome | NCT05674539 | Acute Myeloid L... Myelodysplastic... Allogeneic Hema... | Fludarabine and... Fludarabine and... | 18 Years - | Wuhan Union Hospital, China | |
| Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome | NCT05674539 | Acute Myeloid L... Myelodysplastic... Allogeneic Hema... | Fludarabine and... Fludarabine and... | 18 Years - | Wuhan Union Hospital, China | |
| A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS) | NCT05168904 | Leukemia Myelodysplastic... | fadraciclib | 18 Years - | Cyclacel Pharmaceuticals, Inc. | |
| A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS) | NCT05168904 | Leukemia Myelodysplastic... | fadraciclib | 18 Years - | Cyclacel Pharmaceuticals, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
